13 February 2025

Axol Bioscience: human-relevant iPSC powered in vitro models

Looking to use high-quality iPSC-derived cells in your in vitro projects? Take a look at Axol’s new axoCellsTM Catalog to explore their range of functional iPSC-derived cells for research and drug discovery.


Axol Bioscience is the leading manufacturer of functional iPSC-derived cells and provider of outsourced services to support drug discovery programs.

With over a decade of hard-earned stem cell experience, Axol has become a valued partner to the BioPharma community who look to employ more human-relevant iPSC powered in vitro models for their research. They deliver a complete end-to-end offering from iPSC generation, cell manufacturing, technical services including complex gene-editing, banking, reprogramming and differentiation through to outsourced model building, assay development and compound testing. 

Axol are at the forefront of iPSC-based quality systems, cell characterization and functionality testing, and advanced co-culture model building. They operate according to their values of performance, accountability, transparency, acting with integrity, diversity & inclusivity, and collaboration.

Axol operates in five key market areas:

  • Neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation)
  • Pain & Sensation
  • Ophthalmology (Dry-AMD)
  • Dermatology
  • Cardiovascular

To find out more, take a look at their 2025 axoCellsTM Catalog! This is a comprehensive document to highlight their axoCellsTM range, comprising of human iPSC-derived cells optimized for use in advanced in vitro model systems for research, toxicity screening and drug discovery.

Explore their axoCellsTM Catalog to discover

  • The cells in their key therapy areas: Neuroscience, Pain & Sensation, Cardiovascular, Ophthalmology, and Dermatology
  • The multiple applications of their axoCells range including monoculture, co-culture, microfluidics and organ-on-chip devices
  • Extensive characterization and functional validation data for each of their cell types
  • Details behind their industry-leading quality standards including ISO 9001:2015 and ISSCR compliance
  • Information about the wider products (kits, reagents and supplements), ordering information and their Shipping and Logistics division

Axol have a simple aim: unlocking the benefits of iPSC technology for your research. Their focus on quality, functional performance and consistency has led them to becoming the first choice for iPSC-derived cells in the Neuroscience, Pain & Sensation, Ophthalmology, Dermatology, and Cardiovascular spaces.

Check out their catalog here: 2025 axoCells iPSC Catalog | Axol Bioscience.

Axol Bioscience: human-relevant iPSC powered in vitro models

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support
Contact